Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

KeyCorp (KEY) Announces Buyback, Bigger Dividend on the Way: BB&T Corporation (BBT)

The Comprehensive Capital Analysis and Review results are in, and not surprisingly, KeyCorp (NYSE:KEY) has been given the go-ahead by the Federal Reserve to institute its share buyback program. Considering how well the bank performed on the stress tests, investors likely expected some sharing to be coming their way.

KeyCorp (NYSE:KEY) easily beat the Fed’s minimum requirement of 5% for a stress scenario ratio that included proposed dividend and buyback actions. This means that KeyCorp (NYSE:KEY) will be paying a 10% larger dividend very soon:

Though the dividend is less than last year, when the bank hiked its payout from $0.12 on an annualized basis, to $0.20. KeyCorp (NYSE:KEY) will be embarking upon a share repurchase program, however — and it’s a much larger one than the $344 million buyback that KeyCorp instituted last year.

It’s all about planning
One thing that came through loud and clear regarding CCAR is the fact that planning matters. The Fed looked most kindly on banks that had plump capital cushions post-scary scenario, as well as an airtight capital plan. For those without that dynamic duo, the result was a thumbs-down from regulators.

Just ask Goldman Sachs Group, Inc. (NYSE:GS) and JPMorgan Chase & Co. (NYSE:JPM). These big banks didn’t get an outright objection from the Fed, but they were instructed to submit new capital plans by the end of October to fix weaknesses the Federal Reserve found in their original plans.

For BB&T Corporation (NYSE:BBT) , the news was much worse: an outright objection. Why? Detail are fuzzy, but the Fed notes that it may object to either “qualitative or quantitative concerns” it has about a bank’s plan, based on specifics about that particular bank, or the general economy. For BB&T Corporation (NYSE:BBT), which came through the stress tests with a 9.4% Tier 1 ratio, as well as a 7.76% final, post-severe stress grade, the issue appears to be a change the bank recently made in the way it assesses its risk-weighted assets. Since this value features prominently in the Fed’s formula, BB&T Corporation (NYSE:BBT) failed the test.

Onward and upward for KeyCorp
KeyCorp (NYSE:KEY)’s performance on the Federal Reserve tests, combined with the bank’s outstanding loan growth, net interest margin expansion, and rise in book value have obviously made investors grin. The stock is trading near its 52-week high and will likely continue its upward trajectory. Once again, a regional bank shows that it can hold its own against the big boys.

The article KeyCorp Announces Buyback, Bigger Dividend on the Way originally appeared on and is written by Amanda Alix.

Fool contributor Amanda Alix has no position in any stocks mentioned. The Motley Fool recommends Goldman Sachs. The Motley Fool owns shares of JPMorgan Chase. and KeyCorp.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.